ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 574,01
-0,77%
Dow Jones
40 211,72
0,00%
DAX
18 488,39
-0,60%
Brent Oil
82,835
-1,78%
Bitcoin
63 775,62
-1,66%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
21/10/201922h25Dow Jones NewsOpioid Deal Could Open Door to Bigger Settlement -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/201920h43Dow Jones NewsTeva to Donate Buprenorphine Naloxone Valued at About $23 Billion in Opioid-Related SettlementNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/201919h53Business WireTeva Settles Track 1 Opioid Cases and Reaches Agreement on Framework to Settle Remaining LitigationNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/201916h34Dow Jones NewsFour Drug Companies Reach Last-Minute Settlement in Opioid Litigation -- 3rd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/201914h57Dow Jones NewsFour Drug Companies Reach Last-Minute Settlement in Opioid Litigation -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/201914h21Dow Jones NewsFour Drug Companies Reach Last-Minute Settlement in Opioid Litigation--UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
19/10/201904h48Dow Jones NewsMore Money Demanded in Opioid Settlement Talks -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
19/10/201901h57Dow Jones NewsMore Money Demanded in Opioid Settlement TalksNYSE:TEVATeva Pharmaceutical Industries Ltd
18/10/201909h02Dow Jones NewsBellwether Opioid Deal Talks Ramp Up -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
18/10/201900h15Dow Jones NewsTalks to Settle Opioid Lawsuits IntensifyNYSE:TEVATeva Pharmaceutical Industries Ltd
07/10/201923h00Business WireTeva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019NYSE:TEVATeva Pharmaceutical Industries Ltd
02/10/201914h30Business WireTeva to Present New Data on AUSTEDO® (deutetrabenazine) Tablets at Psych Congress 2019NYSE:TEVATeva Pharmaceutical Industries Ltd
02/10/201914h00Business WireTeva Announces Leadership Change in its Global Operations GroupNYSE:TEVATeva Pharmaceutical Industries Ltd
30/09/201923h41Dow Jones NewsDrugmakers Look to Use Purdue Pharma's Bankruptcy to Settle Opioid SuitsNYSE:TEVATeva Pharmaceutical Industries Ltd
13/09/201919h52Dow Jones NewsCorrection to Opioid Reckoning Hits Money ManagersNYSE:TEVATeva Pharmaceutical Industries Ltd
13/09/201914h29Dow Jones NewsOpioid Reckoning Hits Money ManagersNYSE:TEVATeva Pharmaceutical Industries Ltd
13/09/201911h00PR Newswire (US)INTERCURE: CANNDOC signs strategic distribution agreement with S.L.E. of TEVA PharmaceuticalsNYSE:TEVATeva Pharmaceutical Industries Ltd
05/09/201904h05Business WireTeva präsentiert neue Analysen zur Wirksamkeit und Sicherheit von Fremanezumab bei erwachsenen Patienten mit schwer behandel...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/09/201923h18Business WireTeva présentera de nouvelles analyses sur l'efficacité et l'innocuité du fremanezumab chez les patients adultes atteints d...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/09/201922h14Business WireTeva to Present New Analyses of Fremanezumab Efficacy & Safety in Adult Patients with Difficult-to-Treat Migraine at 19th Con...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/09/201922h05Business WireTeva Announces United States Department of Commerce Appointment of Brendan O’Grady to Investment Advisory CouncilNYSE:TEVATeva Pharmaceutical Industries Ltd
27/08/201922h14Dow Jones NewsShares of Mallinckrodt, Endo, Teva, Drugmakers With Opioid Business, FallNYSE:TEVATeva Pharmaceutical Industries Ltd
21/08/201914h00Business WireFremanezumab Data in The Lancet Demonstrate Clinically Meaningful Reduction in Monthly Migraine Days Versus Placebo for Patie...NYSE:TEVATeva Pharmaceutical Industries Ltd
20/08/201914h00Business WireTeva Announces Availability of a Generic Equivalent of EpiPen Jr® (epinephrine injection, USP) Auto-Injector, 0.15 mg in the...NYSE:TEVATeva Pharmaceutical Industries Ltd
07/08/201921h00Dow Jones NewsTeva Seeks New CFO As It Faces High Debt Levels, Opioid Litigation -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
07/08/201913h05Business WireTeva Announces CFO Leadership TransitionNYSE:TEVATeva Pharmaceutical Industries Ltd
07/08/201913h00Business WireTeva Reports Second Quarter 2019 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
22/07/201917h36Dow Jones NewsFDA Approves Multiple Applications for Generic Version of LyricaNYSE:TEVATeva Pharmaceutical Industries Ltd
17/07/201923h15Dow Jones NewsMedical Distributors Stocks Fall After Opioid Data ReportsNYSE:TEVATeva Pharmaceutical Industries Ltd
15/07/201915h33Dow Jones NewsTeva Pharmaceutical Says FDA Approves AirDuo Digihaler Inhalation PowderNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
ML
Michelin
EU
HO
Thales
EU
BN
Danone
EU
VK
Vallourec
EU
AF
Air FranceKLM
EU
PX4
SBF 120
EU
BEL20
Bel 20
EU
LR
Legrand
EU
CAP
Capgemini
EU
ORA
Orange
NASDAQ
NVDA
NVIDIA
NYSE
MCD
McDonalds
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés